Ország: Új-Zéland
Nyelv: angol
Forrás: Medsafe (Medicines Safety Authority)
Calcium chloride dihydrate 0.2684 mg/mL; Potassium chloride 0.4 mg/mL; Sodium chloride 6 mg/mL; Sodium lactate 3.33 mg/mL (Formed in process from Lactic acid + Sodium hydroxide)
Baxter Healthcare Ltd
Calcium chloride dihydrate 0.2684 mg/mL
Solution for infusion
Active: Calcium chloride dihydrate 0.2684 mg/mL Potassium chloride 0.4 mg/mL Sodium chloride 6 mg/mL Sodium lactate 3.33 mg/mL (Formed in process from Lactic acid + Sodium hydroxide) Excipient: Water for injection
Bag, plastic, Solu-pac, 500 mL
General sale
General sale
Baxter Healthcare Pty Ltd
Compound Sodium Lactate (Hartmanns) infusion solution is indicated as a source of water and electrolytes. It is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. This solution is indicated as a method of intravenous drug delivery, if the drugs are compatible with the solution
Package - Contents - Shelf Life: Bag, plastic, - 500 mL - 24 months from date of manufacture stored at or below 30°C - Bag, plastic, - 1000 mL - 24 months from date of manufacture stored at or below 30°C
1974-08-22
NEW ZEALAND DATA SHEET COMPOUND SODIUM LACTATE (HARTMANNS) Data Sheet 23 May 2019 Page 1 of 13 Baxter Healthcare Ltd 1 COMPOUND SODIUM LACTATE (HARTMANNS), (solution for infusion) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Compound Sodium Lactate (Hartmanns) infusion solution Product Potassium chloride Sodium chloride Sodium lactate Calcium chloride dihydrate Osmolarity α mOsmol/L [Osmolality, mOsmol/kg] Compound Sodium Lactate (Hartmanns) IV infusion 500mL (AHB2323) Potassium chloride 0.04%, Sodium chloride 0.6%, Sodium lactate 0.322% and Calcium chloride dihydrate 0.027% 2.7mmol/ 500mL 51.35mmol/ 500mL 14.36mmol/ 500mL 0.92mmol/ 500mL 280 [254] Compound Sodium Lactate (Hartmanns) IV infusion 1000mL (AHB2324) Potassium chloride 0.04%, Sodium chloride 0.6%, Sodium lactate 0.322% and Calcium chloride dihydrate 0.027% 5.4mmol/L 102.7mmol/L 28.72mmol/L 1.84mmol/L 280 [254] Osmolarity α is a calculated figure; whilst the figures in the brackets are Osmolality [mOsmol/kg]. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for infusion. Appearance COMPOUND SODIUM LACTATE (HARTMANNS), an intravenous (IV) infusion preparation, is a clear, colourless, sterile, non‐pyrogenic solution. COMPOUND SODIUM LACTATE (HARTMANNS) is an isotonic intravenous solution with pH of 5.0 – 7.0. 4 CLINICAL PARTICULARS 4.1 Therapeutic indications COMPOUND SODIUM LACTATE (HARTMANNS) infusion solution is indicated as a source of water and electrolytes. It is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. This solution is indicated as a method of intravenous drug delivery, if the drugs are compatible with the solution. NEW ZEALAND DATA SHEET COMPOUND SODIUM LACTATE (HARTMANNS) Data Sheet 23 May 2019 Page 2 of 13 Baxter Healthcare Ltd 4.2 Dose and method of administration To be used as directed by the physician. The dosage of COMPOUND SODIUM LACTATE (HARTMANNS) infusion solution is dep Olvassa el a teljes dokumentumot